Impact analysis of signals detected from spontaneous adverse drug reaction reporting data

被引:30
|
作者
Waller, P
Heeley, E
Moseley, J
机构
[1] Patrick Waller Ltd, Consultancy Pharmacovigilance Pharmacoepidemiol, Southampton SO30 2NY, Hants, England
[2] Med & Healthcare Prod Regulatory Agcy, Post Licensing Div, London, England
[3] Med & Healthcare Prod Regulatory Agcy, Pharmacoepidemiol Res Team, London, England
关键词
D O I
10.2165/00002018-200528100-00002
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
This paper describes a new method of prioritising signals of potential adverse drug reactions (ADRs) detected from spontaneous reports that is called impact analysis. This is an interim step between signal detection and detailed signal evaluation. Using mathematical screening tools, large numbers of signals may now be detected from spontaneous ADR databases. Regulatory authorities need to rapidly prioritise them and focus on those that are most likely to require significant action. Using two scores ranging from one to 100, each with three input variables, signals may be categorised in terms of the strength of evidence (E) and the potential public health impact (P). In a two-by-two figure with empirically derived cut-off points of ten (the logarithmic mean) for each score, signals are placed in one of four categories (A-D) that are ranked according to their priority (A being the highest and D the lowest). A sensitivity analysis is then performed that tests the robustness of the categorisation in relation to each of the six input variables. A computer program has been written to facilitate the process and reduce error. Further work is required to test the feasibility and value of impact analysis in practice.
引用
收藏
页码:843 / 850
页数:8
相关论文
共 50 条
  • [1] Impact Analysis of Signals Detected from Spontaneous Adverse Drug Reaction Reporting Data
    Patrick Waller
    Emma Heeley
    Jane Moseley
    Drug Safety, 2005, 28 : 843 - 850
  • [2] A comparison of publically available spontaneous adverse drug reaction data from national spontaneous reporting schemes
    Anton, C.
    Cox, A. R.
    Coleman, J. J.
    Ferner, R. E.
    DRUG SAFETY, 2006, 29 (10) : 914 - 914
  • [3] Detecting high-quality signals of adverse drug-drug interactions from spontaneous reporting data
    Zhan, Chen
    Roughead, Elizabeth
    Liu, Lin
    Pratt, Nicole
    Li, Jiuyong
    JOURNAL OF BIOMEDICAL INFORMATICS, 2020, 112
  • [5] A Method to Combine Signals from Spontaneous Reporting Systems and Observational Healthcare Data to Detect Adverse Drug Reactions
    Ying Li
    Patrick B. Ryan
    Ying Wei
    Carol Friedman
    Drug Safety, 2015, 38 : 895 - 908
  • [6] A Method to Combine Signals from Spontaneous Reporting Systems and Observational Healthcare Data to Detect Adverse Drug Reactions
    Li, Ying
    Ryan, Patrick B.
    Wei, Ying
    Friedman, Carol
    DRUG SAFETY, 2015, 38 (10) : 895 - 908
  • [7] Enhancing antidepressant safety surveillance: comparative analysis of adverse drug reaction signals in spontaneous reporting and healthcare claims databases
    Kim, Taehyung
    Jiang, Xinying
    Noh, Youran
    Kim, Maryanne
    Hong, Song Hee
    FRONTIERS IN PHARMACOLOGY, 2024, 14
  • [8] Patterns of adverse drug reaction reporting in Ethiopia: A database analysis of spontaneous reports from 2013 to 2018
    Anebo, Zelalem Gebretsadik
    Abacioglu, Nurrettin
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2022, 15 (02) : 56 - 62
  • [9] Patterns of adverse drug reaction reporting in Ethiopia: A database analysis of spontaneous reports from 2013 to 2018
    Zelalem Gebretsadik Anebo
    Nurrettin Abacioglu
    Asian Pacific Journal of Tropical Medicine, 2022, (02) : 56 - 62
  • [10] Spontaneous Adverse Drug Reaction Reporting in Rural Districts of Mozambique
    Esperança Sevene
    Alda Mariano
    Ushma Mehta
    Maria Machai
    Alexander Dodoo
    David Vilardell
    Sam Patel
    Karen Barnes
    Xavier Carné
    Drug Safety, 2008, 31 : 867 - 876